Compared to controls, BLEO‐IPF mice demonstrated significant and widespread gene regulations, involving several pathways associated with ECM organization, the immune system and TGF‐β signaling, being generally manifest from day 7 after BLEO administration (Figure 6e, Figure S6,S7). The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.